Apply For FDI


Fraud Warning Disclaimer : FDI India warns you against certain individuals that might falsely present themselves as our affiliate agents, representatives, or employees. Under this false pretence, they might try to gain access to your personal information or to acquire money as Consultation fee or any other form or other valuables from you by offering fictitious employment opportunities or by claiming that they are contacting you on our behalf. Don’t fall prey into the fraudulent misrepresentation. Such fraudulent claims and offers are received generally via email, text message, phone, or internet, etc.

FDI India would like to bring to your notice that our authorized official Email ID is, . FDI India shall not be liable for any claims, damage, or loss of any kind inflicted by any other unauthorized entity. Be very mindful of such scams.
Legal : We own all the information, images, text, logo, and other content provided by us. The use of information is strictly prohibited without our consent. We hold the right to take a legal action against any individual or organization violating or using our site information.
Become A Partner Apply For FDI
Fdi India news

Swedish MNC Medicover Sees India's Healthcare Potential

    15 March , 2023         Fdiindia

Swedish MNC Medicover Sees India's Healthcare Potential

Sweden's headquartered multinational hospital chain Medicover plans to double its Indian footprint and expects the size of the country's healthcare market to grow triple times in a decade. 

With a bouquet of 24 hospitals in India, Medicover has indicated that over the next five years, it intends to double the number. 

A specialized provider of diagnostics and healthcare services, the organization operates via two divisions-Diagnostic services and Healthcare services. In its healthcare network, it has a total of 32 hospitals and 129 medical centres. The group's largest markets are India, Poland, and Romania. 

"We believe the healthcare markets in India will triple in size by the next 10 years, from USD 150 billion to over 450 billion. It will grow through multiple sectors. This is a function of the growth of the GDP plus the higher penetration of healthcare spending as a share in a wallet. This will drive significant growth over the next 10 years," as stated by Fredrik Stenmo, Chairman of the group.

As per the review of India's Department of Pharmaceuticals, Foreign Direct Investment (FDI) inflows in the pharmaceutical sector (in both pharmaceuticals and medical devices) in India was Rs 12,097 crore in the financial year 2021-22. 


India Still the Largest Arms Importer in the World

Effects of the Collapse of Key U.S. Bank Decoded Indian CEO